STOCK TITAN
  1. Home
  2. Sec-filings
  3. RTO
  4. [6-K] RENTOKIL INITIAL PLC /FI Current Report (Foreign Issuer)

Rentokil Initial (RTO) grows Q1 2026 revenue 4.3% with 3.4% organic

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Rentokil Initial plc reported first-quarter 2026 revenue of $1,677m, up 4.3% at constant currency with 3.4% Organic Revenue growth. Management described this as a good start in a seasonally quieter period and expressed confidence in delivering a full-year performance in line with market expectations.

North America generated revenue of $995m, up 4.5%, with Pest Control growing organically by 4.1% and strong 12.7% Organic Revenue growth in Business Services helped by pre-spring demand and prior-year contract wins. International revenue was $682m, up 4.1%, with good growth in Europe, Latin America and the UK & Sub-Saharan Africa, partly offset by softer trends in Pacific and MENAT.

By category, Pest Control delivered 3.7% Organic Revenue growth, while Hygiene & Wellbeing grew 2.1% overall, including a decline of (2.7)% organically in North America due to later construction-related revenue. The Group completed 9 bolt-on acquisitions with prior-year annualised revenue of $19m, continuing its M&A-led expansion strategy.

Positive

  • None.

Negative

  • None.
Group revenue Q1 2026 $1,677m Total Group revenue for the quarter
Group organic revenue growth 3.4% Organic Revenue growth in Q1 2026
North America revenue $995m Q1 2026 revenue, up 4.5% at constant currency
North America Business Services organic growth 12.7% Q1 2026 Organic Revenue growth
International revenue $682m Q1 2026 revenue, up 4.1% at constant currency
Pest Control organic growth 3.7% Q1 2026 Organic Revenue growth across the Group
Hygiene & Wellbeing organic growth 2.1% Q1 2026 Organic Revenue growth across the Group
Bolt-on M&A revenue added $19m Annualised revenue in year before acquisition from 9 deals
Organic Revenue growth financial
"Organic Revenue growth was 3.4%."
Organic revenue growth is the increase in a company's sales that comes from its existing products and services, without including any gains from acquisitions or selling off parts of the business. It reflects the company’s ability to attract more customers or encourage existing customers to buy more over time. For investors, it indicates the company's underlying strength and efficiency in expanding its core operations.
constant currency financial
"on a constant currency basis. Organic Revenue growth represents the growth"
Constant currency is a way of measuring financial results that removes the effects of changes in currency exchange rates. It allows for a clearer comparison of a company's performance over time by showing what the numbers would look like if exchange rates had stayed the same. This helps investors understand whether growth comes from actual business improvements or just currency fluctuations.
bolt-on M&A programme financial
"The Group's bolt-on M&A programme continued to create value with 9 deals"
forward-looking statements regulatory
"This communication contains forward-looking statements within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
non-IFRS measures financial
"This communication presents certain non-IFRS measures, which should not be viewed"
Non-IFRS measures are financial figures that companies create on their own to show aspects of their performance, beyond what standard accounting rules require. They can help investors better understand how a company is really doing by highlighting information that might be more relevant or easier to interpret, much like a sports coach emphasizes certain stats to showcase team strengths not captured by official scores.
safe harbour provisions regulatory
"In order to utilise the 'safe harbour' provisions of the U.S."
Form 6-K: How Foreign Companies Report to the SEC →
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
___________________
 
FORM 6-K
 
__________________
 
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of April 2026
 
Commission File Number: 001-41524
___________________________________
 
Rentokil Initial plc
(Registrant’s name)
___________________________________
 
Compass House
Manor Royal
Crawley
West Sussex RH10 9PY
United Kingdom
(Address of principal executive office)
_____________________________________
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F ☒ Form 40-F ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
 
 
 
 
Q1 Trading Update dated 16 April 2026
 
 
 
 
 
 
 
 
16 April 2026
 
 
 
RENTOKIL INITIAL PLC - FIRST QUARTER TRADING UPDATE
 
Rentokil Initial plc ("the Group"), today issues a Trading Update for the first three months of the 2026 financial year covering the period 1 January 2026 to 31 March 2026.
 
 
Mike Duffy, Chief Executive of Rentokil Initial plc, said:
 
"We have made a good start to the year in a seasonally quieter first quarter, with continued momentum in North America and solid progress across our International businesses.
 
"In my first four weeks as CEO, I have been impressed with the depth of passion and pride that our people have in delivering exceptional customer service, and I am excited by the opportunity to unlock the potential of the Group.
 
"While geopolitical events, as previously noted, continue to create some uncertainty, the progress we report today gives us confidence in delivering a full year performance in line with market expectations."
 
 
Group
 
Group Revenue for the quarter was $1,677m, up 4.3%. Organic Revenue growth was 3.4%.
 
 
North America
 
Revenue for the quarter was $995m, up 4.5%.  Organic Revenue growth was 3.9%. 
 
North America Pest Control Revenue growth was 4.7%.  Organic Revenue growth was 4.1%.
●
Pest Control Services Organic Revenue growth was 2.8% (2.6% in Q425), supported by robust price increases and good recovery of weather-related disruption in late January across the US. Performance through the quarter continued to benefit from our growth initiatives focused on enhancing marketing investments and improving sales execution. 
●
Business Services Organic Revenue growth was 12.7% (7.8% in Q425) supported by strong pre-spring demand in product distribution, contribution from 2025 new business wins in brand standards and high-value job work in lake management.
 
Colleague retention increased to 82.6% (FY25: 82.2%) and customer retention was broadly flat at 80.4% (FY25: 80.5%).
 
 
International (Group excluding North America)
 
Revenue for the quarter was $682m, up 4.1%.  Organic Revenue growth was 2.8%.
 
Good growth in Europe, Latin America and the UK & Sub-Saharan Africa was driven by strong pricing and growth in volumes. Pacific and MENAT were a 60bps headwind as the Pacific lapped strong comparatives in Rural and Trackspray, and MENAT experienced disruption from the Middle East conflict.
 
 
Category Performance
 
Pest Control Organic Revenue growth was 3.7%, with 4.1% growth in North America and 2.8% growth in International (3.0% excluding MENAT).
 
Hygiene & Wellbeing Organic Revenue grew by 2.1%, with 2.7% in International and a decline of (2.7)% in North America, impacted by a later phasing of construction timelines delaying Ambius jobbing revenue.   
 
 
M&A
 
The Group's bolt-on M&A programme continued to create value with 9 deals, delivering annualised revenue in the year before acquisition of $19m.
 
 
Conference Details
 
Today, 16 April, at 9:00am BST, Rentokil Initial Chief Financial Officer, Paul Edgecliffe-Johnson will host a conference call for analysts and investors. A replay will be available on the Company website (https://www.rentokil-initial.com/investors.aspx) following the event.
 
To access the live audio webcast, register via the following link:
 
https://www.netroadshow.com/events/login/LE9zwo494GfiEWkBjeE6pecNQUQqzstvPAu
 
Alternatively, to join via teleconference, please register in advance using the link below:
 
https://www.investis-live.com/rentokil/69ca82a0fed46a000febe69d/mfbe
 
 
Enquiries:
 
Investors / Analysts: Heather Wood, Rentokil Initial plc, +44 7808 098793
 
Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199
 
 
Notes:
 
To help understand the underlying trading performance, unless otherwise stated, all commentary and comparable analysis relates to the continuing operations of the Group on a constant currency basis.
 
Organic Revenue growth represents the growth in Revenue at constant currency excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations (pro forma revenue).
 
North America includes Pest Control (Pest Control Services and Business Services) and Hygiene & Wellbeing.
 
North America Pest Control Services is Pest Control excluding Business Services. 
 
 
Summary of Financial Performance
 
 
 
Revenue
 
 
Q1 2026
 
$m
Q1 2025
 
$m
Change (reported)
 
%
Change(constant currency)
%
Organic Revenue Growth%
North America
995
951
4.6%
4.5%
3.9%
Pest Control
965
921
4.8%
4.7%
4.1%
-       Pest Control Services
829
801
3.5%
3.5%
2.8%
-       Business Services
136
120
13.3%
12.7%
12.7%
Hygiene & Wellbeing
30
30
-
(1.5)%
(2.7)%
 
 
 
 
 
 
 
 
 
 
 
 
International
682
605
12.7%
4.1%
2.8%
Pest Control
405
359
   12.8%
4.6%
2.8%
Hygiene & Wellbeing
277
246
12.6%
3.5%
2.7%
 
 
 
 
 
 
Total
1,677
1,556
7.8%
4.3%
3.4%
 
 
Category Performance
 
 
Revenue
 
 
Q1 2026
 
$m
Q1 2025
 
$m
Change (reported)
 
%
Change(constant currency)
%
Organic Revenue Growth%
Pest Control
1,370
1,280
7.0%
4.6%
3.7%
Hygiene & Wellbeing
307
276
11.2%
3.0%
2.1%
Total
1,677
1,556
7.8%
4.3%
3.4%
 
 
Cautionary statement
 
In order to utilise the 'safe harbour' provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the "PSLRA") and the general doctrine of cautionary statements, Rentokil Initial plc ("the Company") is providing the following cautionary statement: This communication contains forward-looking statements within the meaning of the PSLRA. Forward-looking statements can sometimes, but not always, be identified by the use of forward- looking terms such as "believes," "expects," "may," "will," "shall," "should," "would," "could," "potential," "seeks," "aims," "projects," "predicts," "is optimistic," "intends," "plans," "estimates," "targets," "anticipates," "continues" or other comparable terms or negatives of these terms and include statements regarding Rentokil Initial's intentions, beliefs or current expectations concerning, amongst other things, the results of operations of the Company and its consolidated entities ("Rentokil Initial" or "the Group"), financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which Rentokil Initial operates. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialise, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The Company can give no assurance that such plans, estimates or expectations will be achieved and therefore, actual results may differ materially from any plans, estimates or expectations in such forward-looking statements. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include: the Group's ability to integrate acquisitions successfully, or any unexpected costs or liabilities from the Group's disposals; difficulties in integrating, streamlining and optimising the Group's IT systems, processes and technologies, including artificial intelligence technologies; the Group's ability to attract, retain and develop key personnel to lead the Group's business; the availability of a suitably skilled and qualified labour force to maintain the Group's business; cyber security breaches, attacks and other similar incidents, as well as disruptions or failures in the Group's IT systems or data security procedures and those of the Group's third-party service providers; inflationary pressures, such as increases in wages, fuel prices and other operating costs; weakening general economic conditions, including changes in the global job market or decreased consumer confidence or spending levels, especially as they may affect demand from the Group's customers; the Group's ability to implement its business strategies successfully, including achieving its growth objectives; the Group's ability to retain existing customers and attract new customers; the highly competitive nature of the Group's industries; extraordinary events that impact the Group's ability to service customers without interruption due to a material incident, including a loss of its third-party distributors; the impact of environmental, social and governance ("ESG") matters, including those related to climate change and sustainability, on the Group's business, reputation, results of operations, financial condition and/or prospects; supply chain issues, which may result in product shortages, cost increases or other disruptions to the Group's business; the Group's ability to protect its intellectual property and other proprietary rights that are material to the Group's business; the Group's reliance on third parties, including third-party vendors for business process outsourcing initiatives, investment counterparties, and franchisees, and the risk of any termination or disruption of such relationships or counterparty default, fraudulent activity or litigation; any future impairment charges, asset revaluations or downgrades; failure to comply with the many laws and governmental regulations to which the Group is subject or the implementation of any new or revised laws or regulations that alter the environment in which the Group does business, as well as the costs to the Group of complying with any such changes and the risk of related litigation; termite damage claims and lawsuits related thereto and any associated impacts on the termite provision; the Group's ability to comply with safety, health and environmental policies, laws and regulations, including laws pertaining to the use of pesticides; any actual or perceived failure to comply with stringent, complex and evolving laws, rules, regulations and standards in many jurisdictions, as well as contractual obligations, including data privacy and security, and any litigation (including class action claims and lawsuits) related to such actual or perceived failures; the identification of material weaknesses in the Group's internal control over financial reporting within the meaning of Section 404 of the Sarbanes-Oxley Act; changes in tax laws and any unanticipated tax liabilities; adverse credit and financial market events and conditions, which could, among other things, impede access to or increase the cost of financing; the restrictions and limitations within the agreements and instruments governing the Group's indebtedness; a lowering or withdrawal of the ratings, outlook or watch assigned to the Group's debt securities by rating agencies; an increase in interest rates and the resulting increase in the cost of servicing the Group's debt; and exchange rate fluctuations and the impact on the Group's results or the foreign currency value of the Company's ADSs and any dividends. The list of factors presented here is representative and should not be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realisation of forward-looking statements. The Company cautions you not to place undue reliance on any of these forward-looking statements as they are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, the Group's actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which the Group operates, may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Except as required by law, Rentokil Initial assumes no obligation to update or revise the information contained herein, which speaks only as of the date hereof.
 
The Company makes no guarantee that trends in the management of termite damage claims will continue. Additionally, the Company makes no guarantee that its operational improvement plans will mitigate against or reduce the number of termite damage claims (litigated and non-litigated) against the Company nor that these plans will reduce the ongoing cost to resolve such claims.
 
Additional information concerning these and other factors can be found in Rentokil Initial's filings with the U.S. Securities and Exchange Commission ("SEC"), which may be obtained free of charge at the SEC's website, http:// www.sec.gov, and Rentokil Initial's Annual Reports, which may be obtained free of charge from the Rentokil Initial website, https://www.rentokil-initial.com
 
No statement in this communication is intended to be a profit forecast and no statement in this communication should be interpreted to mean that earnings per share of Rentokil Initial for the current or future financial years would necessarily match or exceed the historical published earnings per share of Rentokil Initial.
 
This communication presents certain non-IFRS measures, which should not be viewed in isolation as alternatives to the equivalent IFRS measure, rather they should be viewed as complements to, and read in conjunction with, the equivalent IFRS measure. These include revenue and measures presented at actual exchange rates ("AER" - IFRS) and constant currency ("CER" - Non-IFRS). Non-IFRS measures presented also include Organic Revenue Growth. The Group's internal strategic planning process is also based on these measures, and they are used for incentive purposes. These measures may not be calculated in the same way as similarly named measures reported by other companies.
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: 16 April 2026
RENTOKIL INITIAL PLC
 
/s/ Rachel Canham
 
Name: Rachel Canham
 
Title: Group General Counsel and Company Secretary
 
 


Source: View Original Filing on SEC EDGAR

FAQ

How did Rentokil Initial (RTO) perform in Q1 2026 at the Group level?

Rentokil Initial generated Q1 2026 revenue of $1,677m, up 4.3% at constant currency with 3.4% Organic Revenue growth. This reflects steady expansion in its core Pest Control and Hygiene & Wellbeing activities across North America and International markets.

What were Rentokil Initial (RTO) North America results in Q1 2026?

North America revenue reached $995m in Q1 2026, rising 4.5% at constant currency with 3.9% Organic Revenue growth. Pest Control organic growth was 4.1%, supported by pricing, while Business Services organic growth accelerated to 12.7% on strong product distribution and specialized job work.

How did Rentokil Initial’s International segment perform in Q1 2026?

International revenue was $682m in Q1 2026, up 4.1% at constant currency with 2.8% Organic Revenue growth. Europe, Latin America and the UK & Sub-Saharan Africa showed good growth, while Pacific and MENAT modestly reduced growth due to tough comparatives and regional disruption.

What M&A activity did Rentokil Initial complete in Q1 2026?

Rentokil Initial completed 9 bolt-on acquisitions in Q1 2026, representing combined annualised revenue of $19m in the year before acquisition. These smaller deals support the company’s strategy of adding local capabilities and extending its pest control and hygiene footprint in key markets.

What guidance or outlook did Rentokil Initial (RTO) provide with this update?

Management commented that Q1 2026 showed a good start to the year and reiterated confidence in delivering a full-year performance in line with market expectations. They also noted ongoing geopolitical uncertainty but highlighted continued momentum in North America and solid progress internationally.